Weekly Rundown: Key Catalysts for Small-Cap Stocks (September 15–19)

From recent disclosures to corporate shifts, we’ve highlighted the top small-cap catalysts to watch. Here’s your weekly preview (September 15–19).

--

Companies Participating in the Stifel 2025 Virtual Immunology & Inflammation Forum (September 15–16):

GLUE, VOR, ALMS, CLYM

Companies Participating in iAccess Alpha's Virtual Best Ideas Fall Investment Conference (September 16–17, 2025):

RNXT, CJMB, NNBR, HIT, TOMZ, PRSO, SKYX

Companies Participating in the Q3 Investor Summit Group Virtual Conference (September 16–17):

GNPX, UXIN, DHX, PLX, NAUT

Companies Participating in the Sidoti & Co. Virtual Small-Cap Conference (September 17–18, 2025):

HITI, VNCE, NMTC, UXIN, DYAI

Companies Participating in the TD Cowen 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit (September 17–18, 2025):

ATAI, ANRO, CMPS, VTGN

Additional Companies with Catalysts This Week:

ASRT – Will present new data for SYMPAZAN (clobazam) Oral Film in a poster presentation at the 150th Annual Meeting of the American Neurological Association (ANA2025), September 13–16, 2025, Baltimore Marriott Waterfront, Baltimore.

AMIX – Announced its technology and findings from the first phase of its first-in-human proof-of-concept study will be featured in a podium presentation at the 2025 Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Congress, September 13–17, 2025, Barcelona, Spain.

SABS – Will present at the 61st Annual Meeting of the European Association for the Study of Diabetes (EASD), September 15–19, 2025, Vienna, Austria. Presentations include four oral sessions plus an INNODIA-hosted symposium.

CLRB – Will present “ADCs and Beyond in Radiopharmaceuticals” at BioProcess International on September 15, 2025, at 11:30 AM ET.

BDSX – Presentation at the College of American Pathologists (CAP) 2025 Annual Meeting, September 15, 2025, Orlando, FL. Thermo Fisher–sponsored panel: "Introduction of new IVD solution for rapid NGS profiling in Oncology."

KLTO – CEO and Chairman Dr. Joseph Sinkule will attend the Inaugural Klotho Conference & Scientific Seminar, September 15–16, 2025, UC-Irvine Beal Applied Innovation Center, Irvine, CA.

IRD – Will present one-year results from a Phase I/II study of OPGx-LCA5 subretinal gene therapy at the RD 2025 International Symposium on Retinal Degeneration, September 15, 2025, in Prague, Czech Republic. Presenter: Ash Jayagopal, Ph.D., Chief Scientific & Development Officer. In addition, at the LSX World Congress, Ben Yerxa, Ph.D., President, will participate in a panel discussion titled “The Equation for Maturation: Biotech Requirements to Achieve Scale” on September 17, 2025, at 12:40 PM in Boston, MA.

SKYE – Company will participate in the Obesity Science & Innovation conference in Boston with a keynote panel on September 16, 2025, and present an oral presentation at the EASD Annual Meeting in Vienna on September 19, 2025.

CGEN – Will present research at the Single Cell Genomics 2025 Conference, September 15–17, 2025, Stockholm, Sweden.

SIDU – Participating in World Space Business Week (WSBW), September 15–19, 2025, Paris, France.

FLNT – CEO Don Patrick and CFO Ryan Perfit will participate in the 18th Annual Barrington Research Virtual Fall Investment Conference, September 16, 2025.

PERF – Hosting its Global Beauty & Fashion AI Forum, September 16, 2025, during New York Fashion Week at the Metropolitan Pavilion, NYC.

XPL – CEO Chris Herald will present a live webcast at the 37th Annual Mining Forum Americas 2025, September 16, 2025, at 9:20 AM MT.

AIOT – Management will attend the Barrington Research Virtual Fall Investment Conference, September 16, 2025.

CURI – Participating in the 18ᵗʰ Annual Barrington Research Virtual Fall Investment Conference, September 16, 2025. Also announced a Q3 dividend of $0.08/share payable September 19, 2025.

PBM – Hosting an investor webinar on September 16, 2025, at 12:00 PM ET, featuring its Scientific Advisory Board.

NFGC – CEO Keith Boyle and VP Fiona Childe will attend the Mining Forum Americas 2025, September 14–17, Colorado Springs, CO. Company presentation: September 16, 2025, 1:40 PM MDT.

LUCY – Presenting at the NIBA Conference, September 16–17, 2025, Fort Lauderdale, FL, and exhibiting at Vision Expo West, September 17–20, 2025, Las Vegas, NV.

MTVA – Presenting at the Obesity Science & Innovation 2025 Congress, September 16–17, Boston, MA.

IMUX – Participating in the 2025 Leerink Partners Biopharma Summit, September 17–19, Healdsburg, CA.

SCWO – Presenting at Gabelli Funds’ 3rd PFAS Symposium, September 17, 2025, Harvard Club, NYC.

LXRX – Presenting Phase 2b study results for Pilavapadin at EASD, September 17, 2025, Vienna, Austria.

CLGN – Presenting at the International Conference on Biofabrication 2025, September 14–17, Warsaw, Poland.

CCCC – Oral presentation of Phase 1 trial data at the International Myeloma Society Annual Meeting, September 20, 2025, Toronto, Canada.

NNVC – Presenting at the LSX World Congress 2025, September 17, 2025, Boston, MA.

WGRX – Attending the NIBA Conference, September 17, 2025, Fort Lauderdale, FL.

DAIO – Demonstrating new programming platform at productronica India (Sept 17–19, Bangalore) and SMTA Guadalajara Expo (Sept 17–18, Mexico).

VCIG – Presenting at Smart City Expo KL 2025 (SCEKL25), September 17–19, Kuala Lumpur.

UNCY – Truist Securities Virtual Fireside Chat, September 17, 2025, 10 AM ET.

EVTL – Participating in Vertical Capital Markets Day, September 17, 2025, New York.

YOUL – Hosting a Virtual Investor Event, September 18, 2025, 8:00 AM Beijing/HK (8:00 PM ET, Sept 17).

HNST – Presenting at the Wells Fargo 8th Annual Consumer Conference, September 17, 2025, Dana Point, CA.

ANIX – Presenting at the 13th Annual Ovarcoming Cancer Conference, September 18–19, 2025, Houston, TX (hybrid).

ACRS – Presenting late-breaking Phase 2a results at the EADV Congress, September 17–20, 2025, Paris, France.

ZENA – Participating in the ArcStone-Kingswood Growth Summit 2025, September 18, 2025, St. Regis Toronto.

SLNH – Groundbreaking ceremony for Project Kati, September 18, 2025, Willacy County, TX.

KAPA – Hosting a KOL event, September 18, 2025, 5 PM ET, discussing Phase 2 ENV105 results in prostate cancer.

FFAI – Hosting 919 Futurist Day & Shareholders' Day, September 19, 2025, Los Angeles HQ.

CTKB – Presenting at ESCCA 2025 (Sept 17–20, Montpellier, France) and ICCS 2025.

ATOM – Poster presentation on MST research at Santa Fe Convention Center, September 15–16, 2025.

DYAI – Investor presentation at BioProcess International BPI East, September 15–18, 2025.

BRIA – Declared cash dividend of US$0.133 per Class A share, payable September 30, 2025.

VGZ – CEO Earnest presenting at Mining Forum Americas, September 15, 2025, 4:40 PM MDT, Colorado Springs.

NBY – Declared one-time special cash dividend of $0.80/share, payable September 29, 2025.

XTNT – Announced planned sale of Paradigm Spine GmbH; transaction expected Q3 2025.

COCH – Granted U.S. Patent No. 12,418,758 ("Programming of Cochlear Implant Accessories") on September 16, 2025.

FLUX – Attending International GSE Expo, September 16–18, 2025, Las Vegas, NV.

OPK – Poster presentation at ESPEN Congress, September 13–16, 2025, Prague, Czech Republic.

ELUT – Exhibiting at the Vizient Innovative Technology Exchange, September 17, 2025, Las Vegas, NV.

SUUN – Presenting at the ArcStone-Kingswood Growth Summit, September 18, 2025, Toronto.

UUU – Declared one-time special cash dividend of $1.00/share, record date September 18, payable September 25, 2025.

EVAX – Presenting at HC Andersen Seminar, September 18, 2025, Copenhagen.

NTIP – Declared semi-annual cash dividend of $0.05/share, payable September 29, 2025, to holders of record on September 19, 2025.

--

Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.